The investment seeks to reflect generally the performance of the price of silver. The Trust seeks to reflect such performance before payment of the Trusts expenses and liabilities. It is not actively managed. The Trust does not engage in any activities designed to obtain a profit from, or to amelior... The investment seeks to reflect generally the performance of the price of silver. The Trust seeks to reflect such performance before payment of the Trusts expenses and liabilities. It is not actively managed. The Trust does not engage in any activities designed to obtain a profit from, or to ameliorate losses caused by, changes in the price of silver. Show more
HAYWARD, Calif., June 27, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.Β (Nasdaq:ANTH) (βAntheraβ or the βCompanyβ) announced today that it has withdrawn its request for a hearing to...
Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (βCFAβ)Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (βCNAβ)Further...
HAYWARD, Calif., March 07, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...
HAYWARD, Calif., March 06, 2018 (GLOBE NEWSWIRE) -- Anthera PharmaceuticalsΒ (Nasdaq:ANTH) today announced that Anthera has received formal notice from The NASDAQ Stock Market LLC (βNasdaqβ...
RESULT study reported positive interim futility analyses and completion of dosing, with top line data expected in March 2018Completed private placement for net proceeds of $13.3 million...
HAYWARD, Calif., Feb. 08, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.Β (Nasdaq:ANTH), a biopharmaceutical company focused on developing and commercializing products to treat...
HAYWARD, Calif., Feb. 05, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.Β (Nasdaq:ANTH) is pleased to announce that the final patient has completed the last visit in the primary...
HAYWARD, Calif., Jan. 25, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announcedΒ that on January 24, 2018, Anthera received formal notice that the Nasdaq...
HAYWARD, Calif., Jan. 22, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) today announced a positive outcome of the second, pre-specified interim futility analysis for...
HAYWARD, Calif., Jan. 09, 2018 (GLOBE NEWSWIRE) -- Anthera Pharmaceuticals, Inc.Β (Nasdaq:ANTH) today announced that it has completed the second closing of the private placement of its equity...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -1.4101 | -5.31511496419 | 26.53 | 26.555 | 24.25 | 22305482 | 25.23803747 | SP |
4 | -3.6301 | -12.6264347826 | 28.75 | 28.91 | 24.25 | 18939592 | 26.40299278 | SP |
12 | -1.8601 | -6.89436619718 | 26.98 | 29.56 | 24.25 | 21737259 | 27.36163823 | SP |
26 | 4.6799 | 22.8957925636 | 20.44 | 29.56 | 20.11 | 24617636 | 25.39304288 | SP |
52 | 4.2499 | 20.3636799233 | 20.87 | 29.56 | 18.97 | 20445636 | 23.68264168 | SP |
156 | 3.0299 | 13.7161611589 | 22.09 | 29.56 | 16.19 | 21695990 | 21.8373911 | SP |
260 | 9.3399 | 59.1882129278 | 15.78 | 29.56 | 10.86 | 24802948 | 21.45486679 | SP |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.